Literature DB >> 12069043

Low, but not high, doses of melatonin entrained a free-running blind person with a long circadian period.

Alfred J Lewy1, Jonathan S Emens, Robert L Sack, Brant P Hasler, Rebecca A Bernert.   

Abstract

In a previous report, we were unable to entrain one out of seven totally blind people with free-running endogenous melatonin rhythms to 10 mg of exogenous melatonin. This person had the longest circadian period (24.9 h) of the group. We now find that this person can be entrained to 0.5 mg of melatonin, but not to 20 mg. These results are consistent with the idea that too much melatonin may spill over onto the wrong zone of the melatonin phase-response curve.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12069043     DOI: 10.1081/cbi-120004546

Source DB:  PubMed          Journal:  Chronobiol Int        ISSN: 0742-0528            Impact factor:   2.877


  29 in total

Review 1.  The therapeutic potential of melatonin: a review of the science.

Authors:  Samir Malhotra; Girish Sawhney; Promila Pandhi
Journal:  MedGenMed       Date:  2004-04-13

2.  Clinical implications of the melatonin phase response curve.

Authors:  Alfred Lewy
Journal:  J Clin Endocrinol Metab       Date:  2010-07       Impact factor: 5.958

3.  Does melatonin improve sleep? Muddles with melatonin.

Authors:  M E Jan Wise
Journal:  BMJ       Date:  2006-03-04

4.  A three pulse phase response curve to three milligrams of melatonin in humans.

Authors:  Helen J Burgess; Victoria L Revell; Charmane I Eastman
Journal:  J Physiol       Date:  2007-11-15       Impact factor: 5.182

Review 5.  Chronobiological disorders: current and prevalent conditions.

Authors:  Lia R A Bittencourt; Rogerio Santos-Silva; Marco T de Mello; Monica L Andersen; Sergio Tufik
Journal:  J Occup Rehabil       Date:  2010-03

6.  Nycthemeral variation in melatonin receptor expression in the lymphoid organs of a tropical seasonal breeder Funambulus pennanti.

Authors:  Sameer Gupta; Chandana Haldar
Journal:  J Comp Physiol A Neuroethol Sens Neural Behav Physiol       Date:  2014-11-05       Impact factor: 1.836

7.  Melatonin treatment for eastward and westward travel preparation.

Authors:  Michel A Paul; James C Miller; Gary W Gray; Ryan J Love; Harris R Lieberman; Josephine Arendt
Journal:  Psychopharmacology (Berl)       Date:  2009-12-15       Impact factor: 4.530

8.  A Pre-Screening Questionnaire to Predict Non-24-Hour Sleep-Wake Rhythm Disorder (N24HSWD) among the Blind.

Authors:  Erin E Flynn-Evans; Steven W Lockley
Journal:  J Clin Sleep Med       Date:  2016-05-15       Impact factor: 4.062

Review 9.  Optimal dosages for melatonin supplementation therapy in older adults: a systematic review of current literature.

Authors:  Esmée M S Vural; Barbara C van Munster; Sophia E de Rooij
Journal:  Drugs Aging       Date:  2014-06       Impact factor: 3.923

10.  A multicenter, placebo-controlled trial of melatonin for sleep disturbance in Alzheimer's disease.

Authors:  Clifford Singer; Rochelle E Tractenberg; Jeffrey Kaye; Kim Schafer; Anthony Gamst; Michael Grundman; Ronald Thomas; Leon J Thal
Journal:  Sleep       Date:  2003-11-01       Impact factor: 5.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.